Representative before the EPO

Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 4 EP applications Caroline Chantal Patricia Pallard has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11740860

GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT

IPC classification:
A61P 5/48, C12N 9/12, C07K 14/62, C12N 15/864, A61K 48/00
Agent:
Caroline Chantal Patricia Pallard, Nederlandsch Octrooibureau N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12729529

SELECTIVE ELIMINATION OF EROSIVE CELLS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Novo Nordisk A/S
Agent:
Caroline Chantal Patricia Pallard, Nederlandsch Octrooibureau N.V.
Status:
EXAMINATION IN PROGRESS
EP13165207

Humanized anti-human NKG2A monoclonal antibody

IPC classification:
C07K 16/28
Applicant:
Novo Nordisk A/S
Agent:
Caroline Chantal Patricia Pallard, Nederlandsch Octrooibureau N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764357

NOVEL METHOD FOR DIAGNOSING LYME DISEASE USING A CELLULAR IMMUNOLOGICAL TEST

IPC classification:
G01N 33/68, G01N 33/569
Applicant:
Stichting Katholieke Universiteit
Agent:
Caroline Chantal Patricia Pallard, Nederlandsch Octrooibureau N.V.
Status:
PATENT GRANTED

Please Sign in to use this feature